Wird geladen...
Brusatol, an NRF2 inhibitor for future cancer therapeutic
BACKGROUND: Natural products from herbal medicines have long been investigated for their potentials as cancer therapeutics. Besides the development of several herbal medicine-derived anti-cancer agents, such as paclitaxel, vincristine and podophyllotoxin, many recent laboratory findings demonstrated...
Gespeichert in:
| Veröffentlicht in: | Cell Biosci |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6554866/ https://ncbi.nlm.nih.gov/pubmed/31183074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-019-0309-8 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|